Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2006-12-19 Regulatory Filings
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Vertragsverhandlungen mit zwei Medizintechnikherstellern erstrecken sich uber Jahresende hinaus
Regulatory Filings Classification · 95% confidence The document is a news release dated December 19, 2006, distributed via DGAP (a German news service). It discusses ongoing contract negotiations, expected contract signings in 2007, delays in one-time payments, and new cooperation in the cardiovascular sector. It provides operational updates and financial outlook commentary but is not a formal, comprehensive financial report (like 10-K or IR) nor is it a transcript (CT) or a formal dividend/share change announcement. The content strongly aligns with an 'Earnings Release' (ER) which typically contains key highlights and operational updates preceding a full report, or a general regulatory announcement. Given the nature of providing key business updates and financial commentary (e.g., performance expected to be 15-20% below the previous year's level), it functions as an Earnings Release or a significant corporate update. Since it is not a full report, ER is the most appropriate classification for this type of periodic business update announcement.
2006-12-19 German
Bio-Gate-Tochter BioEpiderm vergroert Produktportfolio und erweitert Geschaftsfuhrung
Board/Management Information Classification · 99% confidence The document is a short corporate news release dated December 11, 2006, distributed via DGAP. The content announces an expansion of the subsidiary BioEpiderm's product portfolio and the addition of a new managing director (Dr. Marcel Langenauer). This type of announcement, detailing changes in senior management and strategic business direction, directly aligns with the definition of Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Given the specific nature of the management change and strategic update, MANG is the most appropriate classification.
2006-12-11 German
Bio-Gate AG: Wechsel im Aufsichtsrat
Board/Management Information Classification · 100% confidence The document text is a short corporate news announcement dated December 5, 2006, titled 'Bio-Gate AG: Wechsel im Aufsichtsrat' (Change in the Supervisory Board). The content explicitly details the resignation of the Chairman of the Supervisory Board and the proposed appointment of new members. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short (4482 chars) and it is a direct announcement, not a report itself.
2006-12-05 German
Bio-Gate-Gruppe erhoht Vertriebschancen fur mikroskaliges Silber in den USA
Legal Proceedings Report Classification · 99% confidence The document is a short news release dated October 5, 2006, detailing a corporate update regarding the Bio-Gate Group receiving confirmation from the US FDA regarding the receipt of necessary documentation (Masterfile) for their silver product (HyGentic4000TM) to be used in the medical market. It is a specific announcement about regulatory progress and market access, not a comprehensive annual report (10-K), an interim report (IR), or a formal earnings release (ER). It is a general corporate announcement concerning business operations and regulatory milestones. Since it doesn't fit perfectly into categories like M&A (TAR), Director's Dealing (DIRS), or Dividend (DIV), and it is a specific regulatory/business update, it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for official corporate news releases that don't match other specific types. Given the length (under 6,000 characters) and the nature of the content (announcing a regulatory step), RNS is the most appropriate general classification.
2006-10-05 German
Bio-Gate AG: Produktsicherheit durch Studie bestatigt
Environmental & Social Information Classification · 99% confidence The document is a short news release dated September 26, 2006, distributed via DGAP (a German news service). It announces that a study confirmed the product safety of Bio-Gate's micro-silver, which improves sales potential in the cosmetics sector, and also mentions appointing a sales representative for Japan. This content is a general corporate update regarding product validation and business development, not a formal financial report (like 10-K, IR, ER) or a specific regulatory filing like insider trading (DIRS) or dividend announcement (DIV). Since it is a general corporate news announcement that doesn't fit the highly specific financial categories, the most appropriate classification is the general regulatory/news fallback category, RNS (Regulatory Filings), as it is a standard news release format.
2006-09-26 German
Bio-Gate AG: Bio-Gate AG bestatigt vorlaufige Zahlen
Earnings Release Classification · 100% confidence The document text reports on the preliminary financial results for the first half of 2006 (Halbjahr 2006), detailing revenue (Umsatz), EBIT, cash flow, and equity position. It explicitly states that the company confirms the preliminary figures previously released on August 9th. Crucially, the last line of the main body states: "Hinweis: Der vollständige ungeprüfte Halbjahresbericht der Bio-Gate Gruppe ist auf der Website des Unternehmens unter http://www.bio-gate.de abrufbar." (Note: The complete unaudited half-year report of the Bio-Gate Group is available on the company's website...). This structure—providing key financial highlights and then directing the reader to the full report elsewhere—is characteristic of an Earnings Release (ER) or a precursor to a full Interim Report (IR). Since it focuses on the period results (first half) and confirms preliminary numbers, it fits the definition of an Earnings Release (ER) which provides initial announcements of periodical financial results (key highlights only). It is not the comprehensive Interim Report (IR) itself, nor is it a general regulatory announcement (RNS) given its specific financial content. H1 2006
2006-08-28 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.